In vivo study targeting CD151 would affect cell survival and anti-CD151 monoclonal antibodies, which, involved in metastasis, may facilitate preventing dissemination of tumor cell and peritoneal spread, which is a critical cause of lethality in HGSC [31]. The gene discussed is CD151; the disease is neoplasm.